Mr. Craig MacPhail reports

NUMINUS WELLNESS PROVIDES UPDATE REGARDING LISTING STATUS

Numinus Wellness Inc. is providing an update regarding its listing status on the Toronto Stock Exchange.

As previously disclosed in the company's management information circular dated July 29, 2025, and as approved by shareholders at the company's annual general meeting held on Aug. 28, 2025 (with voting results subsequently disclosed on Sept. 3, 2025), shareholders authorized the board of directors, in its discretion, to voluntarily delist the company's common shares from the Toronto Stock Exchange if deemed to be in the best interests of the company.

Further to Numinus's news release of March 13, 2026, on March 19, 2026, the continued listing committee of the TSX met and determined to delist the company's common shares from the TSX, effective April 22, 2026. While this delisting does not result from a request from the company, it is consistent with the authorization of the shareholders to delist Numinus from the TSX, and aligns with the company's previously disclosed strategic considerations.

As the company remains subject to a cease trade order, the delisting from the TSX will not change the current trading status of its securities, which are not currently tradable in Canada. The company will continue to be a reporting issuer in all applicable Canadian jurisdictions.

Looking ahead for Numinus, management is pleased to advise that an application has been filed to list the company's shares on the Canadian Securities Exchange. If approved, a listing on the CSE could only take effect after the CTO has been revoked. The listing of the company's common shares on the CSE is subject to the company meeting the CSE's listing requirements, which cannot be guaranteed.

Management remains focused on:

• Completing the work to have the audit completed for the company's financial statements for the year ended Aug. 31, 2026;
• Satisfying all regulatory requirements necessary to have the CTO revoked; and
• Advancing an application to list its common shares on the CSE.

Executing these steps remains management's primary strategy to restore trading, enhance shareholder liquidity and position the company for its next phase of growth.

About Numinus Wellness Inc.

Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model -- including psychedelic research and training -- is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, it is leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

We seek Safe Harbor.